Compare Boston Beer Company Inc (SAM) vs UnitedHealth Group Inc (UNH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Boston Beer Company Inc vs UnitedHealth Group Inc — how do they compare? Boston Beer Company Inc trades at $179.73 (market cap $1.86B), while UnitedHealth Group Inc trades at $405.22 (market cap $361.00B). The key difference: UnitedHealth Group Inc is far larger — about 194.1× Boston Beer Company Inc's market cap, and UnitedHealth Group Inc pays a 2.31% dividend while Boston Beer Company Inc pays none. Which is the better fit depends on your goals.
| SAM | UNH | |
|---|---|---|
Market Cap | $1.86B | $361.00B |
Sector | Consumer Staples | Health |
52-Week High | $260.05 | $436.35 |
52-Week Low | $161.08 | $259.02 |
Enterprise Value | $1.63B | $402.86B |
Dividend Yield | — | 2.31% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Boston Beer (SAM) trades at $183.78, up 1.54% on the day, amid a bearish technical signal and mixed fundamentals. Recent quarterly earnings have missed expectations, with Q2 2026 EPS of $3.65 falling short of the $4.83 estimate, though Q4 2025 beat. The company shows improved net income margins in 2025 but faces revenue pressure and negative ROE/ROA. Analyst consensus is a $207.33 price target with a majority Hold rating, while cash flow trends show recent stabilization after a net outflow in 2024.
The outlook is cautious due to weak volume trends and competitive pressures, offset by a debt-free balance sheet and margin gains. Risks include declining core brands and macroeconomic headwinds, but innovation in RTD beverages offers growth potential. Investors should weigh valuation support against earnings volatility and sentiment headwinds.
UnitedHealth Group (UNH) trades at $408.74, showing modest daily gains of 0.41% amid a bearish technical signal. The company demonstrates strong fundamental performance with consistent earnings beats in recent quarters and robust analyst support (82.7% buy ratings). Recent developments include dividend payments and strategic initiatives to streamline pediatric care authorizations, positioning UNH well in the healthcare sector.
UNH presents a compelling investment case with strong cash flow generation and market leadership, though investors face risks from regulatory scrutiny and margin compression. The stock trades at a discount to analyst consensus target of $476.50, offering potential upside if operational improvements and growth initiatives materialize as projected.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Boston Beer Company Inc
Boston Beer is a leader in U.S. high-end malt beverages and adjacent categories, with strong positions in craft beer, hard cider, and hard seltzer. The firm sells an array of flavor variants and package sizes, predominantly centered around four priority brands: Samuel Adams, Angry Orchard, Twisted Tea, and Truly Hard Seltzer. Its drinks are produced in both company-owned breweries as well as through third-party contract arrangements, and while the company primarily goes to market through independent wholesalers (as mandated by law), it operates a fairly large salesforce to induce demand across the value chain (distributors, retailers, and drinkers). The preponderance of revenue is generated domestically.
Read more on SAM →About UnitedHealth Group Inc
UnitedHealth Group is one of the largest private health insurers, providing medical benefits to 50 million members globally, including 5 million outside the U.S. at the end of 2021. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
Read more on UNH →
